or Try an Advanced Search...

    Technical Analysis for CYTH - Cyclo Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 1.46 -2.67% -0.04
    CYTH closed down 0.66 percent on Wednesday, May 8, 2024, on 18 percent of normal volume.
    Earnings due: May 13
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Flat Up Up
    Historical CYTH trend table...
    Date Alert Name Type % Chg
    Stochastic Sell Signal Bearish -2.67%
    Upper Bollinger Band Walk Strength -2.67%
    Wide Bands Range Expansion -2.67%
    Overbought Stochastic Strength -2.67%
    Upper Bollinger Band Walk Strength -3.31%
    Inside Day Range Contraction -3.31%
    Wide Bands Range Expansion -3.31%
    Overbought Stochastic Strength -3.31%
    Upper Bollinger Band Touch Strength -3.31%
    Upper Bollinger Band Walk Strength -4.58%
    Older End-of-Day Signals for CYTH ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support about 2 hours ago
    200 DMA Support about 2 hours ago
    Outside Day about 3 hours ago
    Fell Below 200 DMA about 3 hours ago
    Fell Below Previous Day's Low about 3 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CYTH Chart by TradingView
    Basic chart:

    Profile

    Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C and Alzheimer’s Disease. The company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is the subject of three ongoing formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease. The company is planning an early phase clinical trial using Trappsol Cyclo intravenously in Alzheimer’s Disease based on encouraging data from an Expanded Access program for late-onset Alzheimer’s Disease. Additional indications for the active ingredient in Trappsol Cyclo are in development.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Clinical Medicine Rare Diseases Alzheimer's Disease Lipid Storage Disorders

    Is CYTH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 10 Pleasing Signs As A Number Of Insiders Buy Cyclo Therapeutics Stock
    Mar 18 Cyclo Therapeutics reports FY results
    Mar 18 Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
    Mar 14 Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease
    Mar 13 Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results
    Jan 29 Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office
    Dec 27 Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.
    Dec 18 Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1
    Dec 14 Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results
    Nov 21 Cyclo Therapeutics to Present at the 20th Annual WORLDSymposium™ 2024
    See more CYTH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.57
    52 Week Low 0.8924
    Average Volume 105,457
    200-Day Moving Average 1.46
    50-Day Moving Average 1.45
    20-Day Moving Average 1.34
    10-Day Moving Average 1.45
    Average True Range 0.11
    RSI (14) 58.16
    ADX 21.68
    +DI 26.40
    -DI 12.89
    Chandelier Exit (Long, 3 ATRs) 1.29
    Chandelier Exit (Short, 3 ATRs) 1.43
    Upper Bollinger Bands 1.59
    Lower Bollinger Band 1.09
    Percent B (%b) 0.81
    BandWidth 37.29
    MACD Line 0.03
    MACD Signal Line -0.01
    MACD Histogram 0.0339
    Fundamentals Value
    Market Cap 42.89 Million
    Num Shares 28.6 Million
    EPS -1.59
    Price-to-Earnings (P/E) Ratio -0.94
    Price-to-Sales 51.42
    Price-to-Book 1.89
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.59
    Resistance 3 (R3) 1.60 1.58 1.58
    Resistance 2 (R2) 1.58 1.55 1.57 1.57
    Resistance 1 (R1) 1.54 1.54 1.53 1.53 1.57
    Pivot Point 1.51 1.51 1.51 1.51 1.51
    Support 1 (S1) 1.48 1.49 1.46 1.47 1.43
    Support 2 (S2) 1.45 1.48 1.45 1.43
    Support 3 (S3) 1.41 1.45 1.42
    Support 4 (S4) 1.41